Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Biagini

Showing results (121-130 of 248) with videos related to

Pageof 25
Sort By:
The American Journal of Cardiology|September 20, 2005
Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypassOlaf Schouten, Virginie H van Waning, Miklos D Kertai, et al.
ESC Heart Failure|May 20, 2020
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitationDavide Stolfo, Matteo Castrichini, Elena Biagini, et al.
Plos One|July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathyRocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
Circulation|October 13, 2004
Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viabilityVittoria Rizzello, Don Poldermans, Eric Boersma, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Journal of the American College of Cardiology|January 5, 2005
Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosisElena Biagini, Abdou Elhendy, Jeroen J Bax, et al.
JACC. Heart Failure|September 25, 2025
Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic CardiomyopathyMilind Y Desai, Niccolo Maurizi, Elena Biagini, et al.
The American Journal of Cardiology|February 2, 2008
Heart transplantation in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Ornella Leone, et al.
The American Journal of Cardiology|April 22, 2005
Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test resultsElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
The American Journal of Cardiology|September 16, 2003
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathyArend F L Schinkel, Manolis Bountioukos, Don Poldermans, et al.
Pageof 25

Showing results (121-130 of 248) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|September 20, 2005
Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypassOlaf Schouten, Virginie H van Waning, Miklos D Kertai, et al.
ESC Heart Failure|May 20, 2020
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitationDavide Stolfo, Matteo Castrichini, Elena Biagini, et al.
Plos One|July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathyRocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
Circulation|October 13, 2004
Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viabilityVittoria Rizzello, Don Poldermans, Eric Boersma, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Journal of the American College of Cardiology|January 5, 2005
Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosisElena Biagini, Abdou Elhendy, Jeroen J Bax, et al.
JACC. Heart Failure|September 25, 2025
Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic CardiomyopathyMilind Y Desai, Niccolo Maurizi, Elena Biagini, et al.
The American Journal of Cardiology|February 2, 2008
Heart transplantation in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Ornella Leone, et al.
The American Journal of Cardiology|April 22, 2005
Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test resultsElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
The American Journal of Cardiology|September 16, 2003
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathyArend F L Schinkel, Manolis Bountioukos, Don Poldermans, et al.
Pageof 25